Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Biotechnology
Healthcare
Get real-time and historical exchange rates for any currency!
Get real-time and historical stock ticker prices for US stocks!
Translate cryptic bank transactions into merchants with logos, address and more!
Brought to you by Synth, a modern fintech API for modern businesses